Virus Neutralization [MoA] - N0000184009

Pharmacologic Code	N0000184009
Pharmacologic Name	Virus Neutralization
Pharmacologic Uses	human immunoglobulin human immunoglobulin G
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

The table contains 8 products whose active ingredient are classified under the same pharmacologic class Virus Neutralization [MoA].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	13533-636	Hyperhep B	Non-Proprietary Name: Hepatitis B Immune Globulin (human)	Injection	Intramuscular	Grifols Usa, Llc	ACTIVE
	49591-051	Hepagam B	Non-Proprietary Name: Human Hepatitis B Virus Immune Globulin	Injection, Solution	Intramuscular; Intravenous	Kamada Ltd.	ACTIVE
	49591-052	Hepagam B	Non-Proprietary Name: Human Hepatitis B Virus Immune Globulin	Injection, Solution	Intramuscular; Intravenous	Kamada Ltd.	ACTIVE
	49591-532	Cytogam	Non-Proprietary Name: Human Cytomegalovirus Immune Globulin	Liquid	Intravenous	Kamada Ltd.	ACTIVE
	60492-0173	Cnj-016	Non-Proprietary Name: Vaccinia Immune Globulin (human)	Injection	Intravenous	Emergent Biosolutions Canada Inc.	ACTIVE
	69800-4203	Nabi-hb	Non-Proprietary Name: Hepatitis B Immune Globulin (human)	Liquid	Intramuscular	Adma Biologics, Inc.	ACTIVE
	70257-051	Hepagam B	Non-Proprietary Name: Hepatitis B Immune Globulin Intravenous (human)	Injection	Intramuscular; Intravenous	Saol Therapeutics Inc.	ACTIVE
	70257-052	Hepagam B	Non-Proprietary Name: Hepatitis B Immune Globulin Intravenous (human)	Injection	Intramuscular; Intravenous	Saol Therapeutics Inc.	ACTIVE